HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of strain-related osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate.

Abstract
The hypothesis tested in this study was that perioperative administration of the bisphosphonate zoledronate will reduce strain protection-related calcar osteopenia and maintain functional integration of the femoral component in an ovine hemiarthroplasty model. Twelve sheep received a unilateral cemented hemiarthroplasty where six animals were given nine intravenous infusions of zoledronate (10 microg/kg) pre-, peri-, and postsurgery over 8 months. Control animals received physiological saline only. Implants remained in vivo for 9 months. Ground reaction force (GRF) was used to assess functional loading of the implanted limb, bone mineral density (BMD) was quantified using dual energy X-ray absorptiometry (DEXA). Cortical bone area, thickness, and viable osteocytes were assessed histologically. No significant differences in GRF data between groups was identified. Results demonstrated a significant drop in BMD values in the control group (9.7%) when compared with the bisphosphonate-treated group (3.2%) (p = 0.0159). Histological results showed that cortical area, thickness, and the percentage of lacunae with viable osteocytes was significantly greater in the bisphosphonate-treated group when compared with control (p = 0.002, p = 0.001, p = 0.003, respectively). The administration of zoledronate reduced cortical osteopenia in the calcar region of the proximal femur and this therapy could be used as a preventive measure to combat strain protection osteopenia and its contribution to associated aseptic loosening in total hip replacement surgery.
AuthorsAllen E Goodship, Gordon W Blunn, Jonathan Green, Melanie J Coathup
JournalJournal of orthopaedic research : official publication of the Orthopaedic Research Society (J Orthop Res) Vol. 26 Issue 5 Pg. 693-703 (May 2008) ISSN: 1554-527X [Electronic] United States
PMID18050308 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright(c) 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
Chemical References
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
Topics
  • Animals
  • Arthroplasty, Replacement, Hip (adverse effects)
  • Bone Density (drug effects)
  • Bone Density Conservation Agents (pharmacology, therapeutic use)
  • Bone Diseases, Metabolic (diagnosis, etiology, prevention & control)
  • Diphosphonates (pharmacology, therapeutic use)
  • Female
  • Hip Joint (pathology)
  • Imidazoles (pharmacology, therapeutic use)
  • Locomotion (drug effects)
  • Microradiography
  • Prosthesis Failure
  • Random Allocation
  • Sheep
  • Stress, Mechanical
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: